1-9 of 9
Johanna Melo-Cardenas, B.Sc
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

BMS-936564 (MDX1338): A Fully Human Anti-CXCR4 Antibody Induces Apoptosis in an in Vitro Model of Stromal – Leukemia Cell Interaction for Chronic Lymphocytic Leukemia.

Manoj Kumar Kashyap, PhD, Deepak Kumar, PhD, Harrison Jones Jones, BS, Michael Y. Choi, MD, Johanna Melo-Cardenas, B.Sc, Michelle R. Kuhne, PhD, Peter Sabbatini, PhD, Lewis Cohen, MD, MS, Suresh Shelat, MD-PhD, Pina M Cardarelli, Ph.D., Thomas J. Kipps, MD, PhD, Januario E. Castro, M.D.
Journal: Blood
Blood (2012) 120 (21): 2887.
https://doi.org/10.1182/blood.V120.21.2887.2887
Published: 2012
Journal Articles

Heat Shock Protein 90 (Hsp90) Activity Status Is An Independent Prognostic Marker in Chronic Lymphocytic Leukemia (CLL) and Correlates with IgV H Mutational Status, ZAP-70 Expression and Time to First Treatment

Januario E. Castro, M.D., Juan S. Barajas-Gamboa, M.D., Julio A. Diaz-Perez, M.D., M.S., Lina M. Ariza-Serrano, M.D. (c), Johanna Melo-Cardenas, B.Sc, Mauricio Rodriguez, D.D.S., M.S., Mauricio Urquiza, Ph.D., Thomas J. Kipps, M.D., Ph.D
Journal: Blood
Blood (2011) 118 (21): 2544.
https://doi.org/10.1182/blood.V118.21.2544.2544
Published: 2011
Journal Articles

Ad-ISF35-Transduced Autologous Cells In Combination with Fludarabine, Cyclophosphamide, Rituximab (FCR) Induces Complete and Partial Responses In a Phase 1b Study for Patients with Fludarabine-Refractory and/or Del(17p)/p53-Defective Chronic Lymphocytic Leukemia (CLL)

Januario E. Castro, M.D., Lee Schwartzberg, MD, FACP, Javier Pinilla-Ibarz, MD, PhD, Johanna Melo-Cardenas, B.Sc, Juan S. Barajas-Gamboa, M.D., Mark J. Cantwell, PhD, Thomas J. Kipps, M.D., Ph.D
Journal: Blood
Blood (2011) 118 (21): 168.
https://doi.org/10.1182/blood.V118.21.168.168
Published: 2011
Journal Articles

Ad-ISF35 Intratumoral Administration Induces a Bystander Effect and Immune-Mediated Tumor Rejection with a Safe Vector Biodistribution and Toxicology Profile In a NHL Mouse Model.

Johanna Melo-Cardenas, B.Sc, Mauricio Urquiza, PhD, Robier Aguillon-Prada, M.D, Thomas J. Kipps, MD, PhD, Januario E Castro, M.D
Journal: Blood
Blood (2010) 116 (21): 1470.
https://doi.org/10.1182/blood.V116.21.1470.1470
Published: 2010
Journal Articles

Ad-ISF35- Transduced Autologous Cells Promote In Vitro and In Vivo Chemosensitization to FCR and Durable Complete Responses In Patients with Del(17p)/P53 Defective Chronic Lymphocytic Leukemia.

Januario E Castro, M.D, Johanna Melo-Cardenas, B.Sc, Juan Sebastian Barajas-Gamboa, M.D, Mauricio Urquiza, PhD, Mark J. Cantwell, PhD, Thomas J. Kipps, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 1472.
https://doi.org/10.1182/blood.V116.21.1472.1472
Published: 2010
Journal Articles

Immune Gene Therapy for Patients with CLL Using Repeat Dose Intranodal Injection of Ad-ISF35, a Replication Incompetent Vector Expressing a Membrane-Stable CD40 Binding Protein.

Januario E Castro, M.D, Johanna Melo-Cardenas, B.Sc, Juan Sebastian Barajas-Gamboa, M.D, Ramin Sean Pakbaz, M.D, Mauricio Urquiza, PhD, Thomas J. Kipps, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 1476.
https://doi.org/10.1182/blood.V116.21.1476.1476
Published: 2010
Journal Articles

Ofatumumab and High-Dose Methylprednisolone Is An Effective Salvage Treatment for Heavily Pretreated, Unfit or Refractory Patients with Chronic Lymphocytic Leukemia: Single Institution Experience

Januario E Castro, M.D, Juan Sebastian Barajas-Gamboa, M.D, Johanna Melo-Cardenas, B.Sc, Rosa N Paz, Cesar Bernal-Corzo, Amine Ale-Ali, Pharm., D., Danelle F. James, M.D, Thomas J. Kipps, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 4638.
https://doi.org/10.1182/blood.V116.21.4638.4638
Published: 2010
Journal Articles

Ad-ISF35-Transduced Autologous Cells Promote in Vitro and In Vivo Chemosensitization to FCR in Patients with Del(17p) / P53 Defective Chronic Lymphocytic Leukemia.

Januario E. Castro, M.D., Johanna Melo-Cardenas, B.Sc, Jose Sandoval-Sus, Mauricio Urquiza, Charles Prussak, PhD, Thomas J. Kipps, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 376.
https://doi.org/10.1182/blood.V114.22.376.376
Published: 2009
Journal Articles

A Phase I Study of Immune Gene Therapy for Patients with CLL Using Intranodal Injection of ISF35, a Membrane-Stable CD40 Binding Protein.

Januario Castro, MD, Jose D. Sandoval, MD, Johanna Melo-Cardenas, B.Sc, Denise Darrah, RN, Mauricio Urquiza, PhD, Charles Prussak, PhD, Thomas J. Kipps, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 2100.
https://doi.org/10.1182/blood.V112.11.2100.2100
Published: 2008